JAMIE TIGNER: Open Payments
NPI 1568766251 · BEND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 35 payments from 8 companies in 2025. Trend: 2023 $743 · 2024 $617 · 2025 $794
Food & beverage: $785Education: $9
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $304 |
| Janssen Biotech, Inc. | 12 | $283 |
| Lilly USA, LLC | 1 | $77 |
| PFIZER INC. | 2 | $38 |
| GENZYME CORPORATION | 2 | $34 |
| Aimmune Therapeutics, Inc. | 2 | $32 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $9 |
Products named: TREMFYA, SKYRIZI, OMVOH, RINVOQ, XELJANZ, DUPIXENT, ZENPEP, MAVYRET.
Industry payments across OR — which companies pay providers there.
